Drug recall · October 3, 2018
Minivelle recall
Why: Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Minivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6625-8
- Lots / codes
Lots: 82199 Exp. 12/2018; 83025 Exp. 05/2019
- Quantity
- 26217 boxes of 8 patches
- Company
- Noven Pharmaceuticals, Inc., Miami, FL
- Distribution
- Nationwide
- Initiated
- September 7, 2018 · Voluntary: Firm initiated
- Classified
- September 25, 2018
- Reported
- October 3, 2018
- Ended
- September 9, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Minivelle
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.